- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 50
Corporate venturing deal net: 22-26 March 2021
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 26, 2021Avanti gets corporate aid to raise $37m
Coinbase, Banca del Ceresio, ECMC and SIG were among the participants in a series A round that took the digital asset banking startup's total funding to $44m.
Mar 26, 2021Maersk takes Baton to series A round
Trucking distribution system developer Baton raised $10.5m in a round co-led by Maersk Growth that included Prologis Ventures, Lineage Logistics and RyderVentures.
Mar 25, 2021Yaguara strikes Chord as the right acquisition
Chord has paid an undisclosed amount to purchase the customer data sofware provider, which had raised $7.2m from investors including Gradient Ventures last year.
Mar 25, 20211910 Genetics makes $22m date with Microsoft
M12 co-led a $22m series A round for the drug discovery technology developer with Playground Global, and both investors have taken board seats.
Mar 24, 2021AppliedVR accelerates with $29m
Cedars-Sinai contributed to a round boosting the virtual reality therapeutics developer's overall funding to $35m.
Mar 24, 2021XMirror extracts $15m from investors
The DevSecOps software developer received $15m in a series A round led by Tencent and backed by existing investor Sequoia China.
Mar 24, 2021Meatable meets investors for $47m series A
DSM Venturing was among the investors in a round that will help the lab-grown meat developer widen its product range.
Mar 24, 2021DexCare executes $20m series A
Providence's health capacity management system has been spun off with $20m from investors including Providence Ventures and Kaiser Permanente Ventures
Mar 23, 2021NovoCodex selects Eli Lilly for series A
Lilly Asia Ventures co-led a $61.4m round for the antibody drug developer that will fund development of breast and gastric cancer drug candidates.
Mar 23, 2021
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.